The Greater Zurich Area is Well-positioned in the Life Sciences in Switzerland and Europe.
The Greater Zurich Area has become a hub for the life sciences industry in recent years, with above-average numbers of medtech companies and brisk spin-off activities from the Zurich universities. The spin-offs have established themselves near their scientific origins, in incubators and parks where they have access to functional and affordable laboratory infrastructures. Numerous cluster initiatives and networks foster exchanges between start-ups, established companies and academia. An international regional comparison conducted within the framework of the EU HealthTIES project gave the region of Zurich a good score in the life sciences area. The detailed comparison shows that Zurich is strong in the academic field and the existing companies are well-positioned. However, weaknesses are evident in the field of clinical research and in the interface between academia and industry. The infrastructure offerings in the Greater Zurich Area for life sciences companies and for exchanges between academia and industry will be further expanded in the coming years. Whether the high growth rate of the industry in the Greater Zurich Area can be maintained or even increased depends on the economy and other factors, but also on the political environment.